Home Cart 0 Sign in  

[ CAS No. 93609-84-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 93609-84-8
Chemical Structure| 93609-84-8
Structure of 93609-84-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 93609-84-8 ]

Related Doc. of [ 93609-84-8 ]

Alternatived Products of [ 93609-84-8 ]

Product Details of [ 93609-84-8 ]

CAS No. :93609-84-8 MDL No. :MFCD19381743
Formula : C18H15NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :MVYPGJMOODJFAZ-UHFFFAOYSA-N
M.W : 293.32 Pubchem ID :13375444
Synonyms :

Calculated chemistry of [ 93609-84-8 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.17
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 86.0
TPSA : 55.73 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.35
Log Po/w (XLOGP3) : 2.21
Log Po/w (WLOGP) : 1.27
Log Po/w (MLOGP) : 2.05
Log Po/w (SILICOS-IT) : 4.6
Consensus Log Po/w : 2.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.19
Solubility : 0.189 mg/ml ; 0.000645 mol/l
Class : Soluble
Log S (Ali) : -3.01
Solubility : 0.283 mg/ml ; 0.000966 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.92
Solubility : 0.000352 mg/ml ; 0.0000012 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.49

Safety of [ 93609-84-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 93609-84-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 93609-84-8 ]
  • Downstream synthetic route of [ 93609-84-8 ]

[ 93609-84-8 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 100-39-0 ]
  • [ 62978-73-8 ]
  • [ 93609-84-8 ]
YieldReaction ConditionsOperation in experiment
91.7% With N-ethyl-N,N-diisopropylamine In water; acetone for 6 - 7 h; Heating / reflux Crude 5-ACETYL-8-HYDROXY-(1H)-QUINOLIN-2-ONE (8.13 g, 40 mmol, 1.0 eq. ) is added to N- N, diisopropylethylamine (6.46 g, 50 mmol, 1.25 eq. ) and acetone (64 mL). The suspension is heated to reflux temperature and water is added (8.2 mL). Benzylbromide (7.52 g, 44 mmol, 1.10 eq. ) is added drop-wise and the reaction is maintained for 6-7 hours at reflux temperature until all starting material has reacted. Water (20 mL) is added at IT = 58 °C and the mixture is cooled down to 20-25 °C. The product is filtered, washed with acetone/water (1/1,2 x 8.5 mL) and then with water (4 x 8 mL). The crude product is dried overnight under vacuum (60 °C). Yield: 10.77 g (91.7percent). Purity of the crude product: 99.5percent. The product may be recrystallized from acetone/water.
91.7% With N-ethyl-N,N-diisopropylamine In acetone for 6 - 7 h; Heating / reflux Example 5; Preparation of 5-acetyl-8-benz,Ylo , -x(at)Il(at)duinolin-2-one; [Crude 5-acetyl-8-hydroxy-(lM-quinolin-2-one (8.13 g, 40 mmol, 1.0 eq.) is added to N- N, diisopropylethylamine (6.46 g, 50 mmol, 1.25 eq. ) and acetone (64 mL). The suspension is heated to reflux temperature and water is added (8.2 mL). Benzylbromide (7.52 g, 44 mmol, 1.10 eq. ) is added drop-wise and the reaction is maintained for 6-7 hours at reflux temperature until all starting material has reacted. Water (20 mL) is added at IT = 58 °C and the mixture is cooled down to 20-25 °C. The product is filtered, washed with acetone/water (1/1, 2 x 8.5 mL) and then with water (4 x 8 mL). The crude product is dried overnight under vacuum (60 °C) . Yield: 10.77 g (91.7percent). Purity of the crude product: 99.5percent. The product may be recrystallised from acetone/water.
48 g
Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667 h;
Stage #2: at 20℃; for 2.5 h;
To a solution of 5-acetyl-8-hydroxy-(1H)-quinolin-2-one (35 g) in dimethylformamide (175 ml) potassium carbonate (35 g) was added at room temperature and stirred for 10 minutes. To the suspension, benzylbromide (32 g) was slowly added over a period of 30 minutes and stirred for 2 hours at the same temperature for completion of reaction (monitored by TLC). The reaction mass was diluted with water (800 ml) and stirred for 20 minutes for the product to precipitate out. The product was filtered, washed with water and dried under vacuum to get the title product (48 g).
Reference: [1] Patent: WO2004/87668, 2004, A1, . Location in patent: Page 29
[2] Patent: WO2005/123684, 2005, A2, . Location in patent: Page/Page column 34
[3] Patent: US2004/224982, 2004, A1, . Location in patent: Page 10
[4] Patent: US2004/242622, 2004, A1, . Location in patent: Page 29
[5] Patent: US2004/167167, 2004, A1, . Location in patent: Page/Page column 32
[6] Patent: US2006/35933, 2006, A1, . Location in patent: Page/Page column 25
[7] Patent: US2006/35931, 2006, A1, . Location in patent: Page/Page column 13
[8] Patent: US2003/153597, 2003, A1,
[9] Patent: WO2006/23457, 2006, A1, . Location in patent: Page/Page column 65
[10] Patent: US2003/229058, 2003, A1, . Location in patent: Page 47
[11] Patent: WO2004/89892, 2004, A2, . Location in patent: Page 83
[12] Patent: US2005/182092, 2005, A1, . Location in patent: Page/Page column 11
[13] Patent: US2012/46467, 2012, A1, . Location in patent: Page/Page column 20
[14] Patent: US2018/215714, 2018, A1, . Location in patent: Paragraph 0069
  • 2
  • [ 100-44-7 ]
  • [ 62978-73-8 ]
  • [ 93609-84-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 1984, vol. 19, # 4, p. 341 - 346
[2] Patent: US4579854, 1986, A,
  • 3
  • [ 100331-93-9 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: WO2008/104781, 2008, A1, . Location in patent: Page/Page column 38-39
  • 4
  • [ 22614-69-3 ]
  • [ 93609-84-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 1984, vol. 19, # 4, p. 341 - 346
  • 5
  • [ 15450-76-7 ]
  • [ 93609-84-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 1984, vol. 19, # 4, p. 341 - 346
  • 6
  • [ 62978-76-1 ]
  • [ 93609-84-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 1984, vol. 19, # 4, p. 341 - 346
  • 7
  • [ 148-24-3 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: US2012/46467, 2012, A1,
[2] Patent: WO2008/104781, 2008, A1,
  • 8
  • [ 1127-45-3 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: US2012/46467, 2012, A1,
  • 9
  • [ 15450-72-3 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: US2012/46467, 2012, A1,
  • 10
  • [ 2598-31-4 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: WO2008/104781, 2008, A1,
  • 11
  • [ 26872-48-0 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: WO2008/104781, 2008, A1,
  • 12
  • [ 57434-96-5 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: WO2008/104781, 2008, A1,
  • 13
  • [ 100-39-0 ]
  • [ 93609-84-8 ]
Reference: [1] Patent: WO2008/104781, 2008, A1,
  • 14
  • [ 93609-84-8 ]
  • [ 530084-79-8 ]
Reference: [1] Patent: US2012/46467, 2012, A1,
[2] Patent: WO2012/168349, 2012, A1,
[3] Patent: WO2012/168359, 2012, A1,
[4] Patent: US2013/34504, 2013, A1,
[5] Patent: US2014/161736, 2014, A1,
[6] Patent: US2014/163066, 2014, A1,
[7] Patent: WO2014/86924, 2014, A1,
[8] Patent: US2016/235734, 2016, A1,
[9] Patent: WO2016/193241, 2016, A1,
[10] Patent: WO2017/93208, 2017, A1,
[11] Patent: WO2007/102771, 2007, A1,
[12] Patent: WO2008/104781, 2008, A1,
  • 15
  • [ 93609-84-8 ]
  • [ 100331-89-3 ]
YieldReaction ConditionsOperation in experiment
75.7% With bromine; trifluoroborane diethyl ether; potassium carbonate In dichloromethane (1)
A solution of 7.8 g of bromine in 30 ml of methylene chloride is added dropwise to a refluxing solution of 13 g of 5-acetyl-8-benzyloxycarbostyril and 7.56 g of boron trifluoride etherate in 170 ml of methylene chloride, and the mixture is refluxed for 30 minutes under heating.
The mixture is concentrated under reduced pressure to remove solvent.
The residue is made alkaline with an aqueous 10percent potassium carbonate solution, and the resultant precipitates are collected by filtration.
The crystals are recrystallized from a mixture of chloroform and methanol.
12.51 g of 5-bromoacetyl-8-benzyloxycarbostyril are obtained as pale yellow needles. Yield: 75.7percent
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; Preparation intermediate 38-(Benzyloxy)-5-(2-bromoacetyl)quinolin-2(l )-oneTo a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(lH)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL) a solution of tetra-n-butylammonium tribromide (54.5 g, 1 13.0 mmol) in anhydrous THF (130 mL) was added dropwise over 1.5 hours. The resulting solution was stirred at RT overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mL). Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling. The resulting suspension was filtered and the solid washed with water and dried under vacuum. The solid was suspended in dichloromethane and methanol (1 : 1 v/v, 100 mL) for 90 minutes. The solid was collected by filtration, washed with dichloromethane and air-dried to afford the title compound (18.0 g, 73percent). NMR (400 MHz, CDCl3-d): δ 9.23 (br s, 1 H), 8.78 (d, 1 H), 7.67 (d, 1 H), 7.40 (s, 5 H), 7.03 (d, 1 H), 6.75 (d, 1 H), 5.25 (s, 2 H), 4.42 (s, 2 H).
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; To a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(lH)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL) was added a solution of tetra-n-butylammonium tribromide (54.5 g, 1 13.0 mmol) in anhydrous THF (130 mL) dropwise over 1.5 hours. The resulting solution was stirred at RT overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mL). Saturated aqueous ammonium chloride solution (390 mL) was added with ice- cooling. The resulting suspension was filtered and the solid washed with water and air-dried under vacuum. The solid was suspended in DCM and methanol (1 : 1 v/v, 100 mL) for 90 minutes. The solid was collected by filtration, washed with DCM and air-dried to afford the title compound (18.0 g, 73percent). NMR (400 MHz, DMSO-d6): δ 1 1.07 (s, 1 H), 8.51 (d, J = 10.0 Hz, 1 H), 7.94-7.83 (m, 1 H), 7.60 (d, J = 7.5 Hz, 2 H), 7.44-7.27 (m, 4 H), 6.79-6.65 (m, 1 H), 5.53-5.39 (s, 2 H); 4.93 (s, 2 H)
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; To a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(1H)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL), a solution of tetra-n-butylammonium tribromide (54.5 g, 113.0 mmol) in anhydrous THF (130 mL) was added dropwise over 1.5 hours.
The resultant solution was stirred at RT overnight before concentrating under reduced pressure without heating.
The residue was re-dissolved in methanol (200 mL).
Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling.
The resultant suspension was filtered, and the solid was washed with water and dried under vacuum.
The solid was suspended in dichloromethane and methanol (1:1 v/v, 100 mL) for 90 minutes.
The solid was collected by filtration, washed with dichloromethane and air-dried to afford the title compound (18.0 g, 73percent).
1H NMR (400 MHz, CDCl3): δ 9.23 (br s, 1H), 8.78 (d, 1H), 7.67 (d, 1H), 7.40 (s, 5 H), 7.03 (d, 1H), 6.75 (d, 1H), 5.25 (s, 2H), 4.42 (s, 2H).
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; Step 1:
8-(Benzyloxy)-5-(2-bromoacetyl)quinolin-2(1H)-one
To a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(1H)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL) was added a solution of tetra-n-butylammonium tribromide (54.5 g, 113.0 mmol) in anhydrous THF (130 mL) dropwise over 1.5 hours.
The resulting solution was stirred at RT overnight before concentrating under reduced pressure without heating.
The residue was re-dissolved in methanol (200 mL).
Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling.
The resulting suspension was filtered and the solid washed with water and air-dried under vacuum.
The solid was suspended in DCM and methanol (1:1 v/v, 100 mL) for 90 minutes.
The solid was collected by filtration, washed with DCM and air-dried to afford the title compound (18.0 g, 73percent).
1H NMR (400 MHz, DMSO-d6): δ 11.07 (s, 1H); 8.51 (d, J=10.0 Hz, 1H); 7.94-7.83 (m, 1H); 7.60 (d, J=7.5 Hz, 2H); 7.44-7.27 (m, 4H); 6.79-6.65 (m, 1H); 5.53-5.39 (s, 2H); 4.93 (s, 2H)
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; A suspension of 5-acetyl-8-(benzyloxy)quinolin-2(lH)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 niL) and anhydrous methanol (165 niL) was added with a solution of fctra-n-butylammonium tribromide (Bu4NBr3) (54.5 g, 1 13.0 mmol) in anhydrous THF (130 mL) dropwise over 1.5 hours. The resulting solution was stirred at RT overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mL). Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling. The resulting suspension was filtered and the solid washed with water and air-dried under vacuum. The solid was suspended in DCM and methanol (1 : 1 v/v, 100 mL) for 90 minutes. The solid was collected by filtration, washed with DCM and air- dried to afford the title compound (18.0 g, 73percent). 1HNMR (400 MHz, DMSO-d6): δ 1 1.07 (s, 1 H); 8.51 (d, J = 10.0 Hz, 1 H); 7.94- 7.83 (m, 1 H); 7.60 (d, J = 7.5 Hz, 2 H); 7.44-7.27 (m, 4 H); 6.79-6.65 (m, 1 H); 5.53-5.39 (s, 2 H); 4.93 (s, 2 H)
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; A suspension of 5-acetyl-8-(benzyloxy)quinolin-2 (1H)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mE) and anhydrous methanol (165 mE) was added with a solution of tetra-n-butylammonium tribromide (54.5 g, 113.0 mmol) in anhydrous THF (130 mE) drop-wise over 1.5 hours. The resulting solution was stirred at room temperature overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mE). Saturated aqueous ammonium chloride solution (390 mE) was added with ice-cooling. The resulting suspension was filtered and the solid washed with water and air-dried under vacuum. The solid was suspended in DCM and methanol (1:1 v/v, 100mE) for 90 minutes. The solid was collected by filtration, washed with DCM and air-dried to afford the title compound(18.0 g, 73percent). 1H NMR (400 MHz, DMSO-d5): ö 11.07 (s, 1H),8.51 (d, J=10.OHz, 1H), 7.94-7.83 (m, 1H), 7.60 (d, J=7.5 Hz,2H), 7.44-7.27 (m, 4H), 6.79-6.65 (m, 1H), 5.53-5.39 (s, 2H),4.93 (s, 2H)
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; To a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(1H)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL) was added a solution of tetra-n-butylammonium tribromide (54.5 g, 113.0 mmol) in anhydrous THF (130 mL) drop-wise over 1.5 hours. The resulting solution was stirred at room temperature overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mL). Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling. The resulting suspension was filtered and the solid washed with water and air-dried under vacuum. The solid was suspended in DCM and methanol(1 : 1 v/v, 100 mL) for 90 minutes. The solid was collected by filtration, washed with DCM and air-dried to afford the title compound (18.0 g, 73percent). NMR (400 MHz, DMSO-d6): δ 11.07 (s, 1 H), 8.51 (d, J = 10.0 Hz, 1 H),7.94-7.83 (m, 1 H), 7.60 (d, J = 7.5 Hz, 2 H), 7.44-7.27 (m, 4 H), 6.79-6.65 (m, 1 H), 5.53-5.39 (s, 2 H), 4.93 (s, 2 H)
73% With tetra-N-butylammonium tribromide In tetrahydrofuran; methanol at 20℃; To a suspension of 5-acetyl-8-(benzyloxy)quinolin-2(lH)-one (19.4 g, 66.4 mmol) in anhydrous THF (240 mL) and anhydrous methanol (165 mL) was added a solution of tetra-n-butylammonium tribromide (54.5 g, 113.0 mmol) in anhydrous THF (130 mL) drop- wise over 1.5 hours. The resulting solution was stirred at room temperature overnight before concentrating under reduced pressure without heating. The residue was re-dissolved in methanol (200 mL). Saturated aqueous ammonium chloride solution (390 mL) was added with ice-cooling. The resulting suspension was filtered and the solid washed with water and air-dried under vacuum. The solid was suspended in DCM and methanol (1 :1 v/v, 100 mL) for 90 minutes. The solid was collected by filtration, washed with DCM and air-dried to afford the title compound (18.0 g, 73percent). NMR (400 MHz, DMSO-d6): δ 11.07 (s, 1 H), 8.51 (d, J= 10.0 Hz, 1 H), 7.94- 7.83 (m, 1 H), 7.60 (d, J= 7.5 Hz, 2 H), 7.44-7.27 (m, 4 H), 6.79-6.65 (m, 1 H), 5.53-5.39 (s, 2 H), 4.93 (s, 2 H)

Reference: [1] Patent: US4579854, 1986, A,
[2] Patent: WO2012/168349, 2012, A1, . Location in patent: Page/Page column 30-31
[3] Patent: WO2012/168359, 2012, A1, . Location in patent: Page/Page column 56; 57
[4] Patent: US2013/34504, 2013, A1, . Location in patent: Paragraph 0120; 0121; 0122
[5] Patent: US2014/163066, 2014, A1, . Location in patent: Paragraph 0209-0211
[6] Patent: WO2014/86924, 2014, A1, . Location in patent: Page/Page column 40; 41
[7] Patent: US2016/235734, 2016, A1, . Location in patent: Paragraph 0355; 0356; 0357
[8] Patent: WO2016/193241, 2016, A1, . Location in patent: Page/Page column 37-38
[9] Patent: WO2017/93208, 2017, A1, . Location in patent: Page/Page column 28; 29
[10] Patent: US2004/224982, 2004, A1, . Location in patent: Page 10
[11] Patent: US2004/242622, 2004, A1, . Location in patent: Page 29-30
[12] Patent: US2004/167167, 2004, A1, . Location in patent: Page/Page column 34
[13] Patent: EP1574501, 2005, A1, . Location in patent: Page/Page column 22-23
[14] Patent: US2006/35933, 2006, A1, . Location in patent: Page/Page column 25
[15] Patent: US2006/35931, 2006, A1, . Location in patent: Page/Page column 13
[16] Patent: WO2006/23457, 2006, A1, . Location in patent: Page/Page column 65
[17] Patent: US4579854, 1986, A,
[18] Patent: US2003/229058, 2003, A1, . Location in patent: Page 47-48
[19] Patent: WO2004/89892, 2004, A2, . Location in patent: Page 83
[20] Patent: US2005/182092, 2005, A1, . Location in patent: Page/Page column 11
[21] Patent: US2012/46467, 2012, A1, . Location in patent: Page/Page column 20
[22] Patent: US2018/215714, 2018, A1, . Location in patent: Paragraph 0070
[23] Patent: WO2007/102771, 2007, A1, . Location in patent: Page/Page column 63
[24] Patent: WO2008/104781, 2008, A1, . Location in patent: Page/Page column 39-40
  • 16
  • [ 93609-84-8 ]
  • [ 100331-89-3 ]
Reference: [1] Patent: US2014/161736, 2014, A1, . Location in patent: Page/Page column
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 93609-84-8 ]

Aryls

Chemical Structure| 1477-19-6

[ 1477-19-6 ]

(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

Similarity: 0.57

Chemical Structure| 129722-25-4

[ 129722-25-4 ]

7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one

Similarity: 0.56

Chemical Structure| 34589-97-4

[ 34589-97-4 ]

2-Amino-1-(2-methoxyphenyl)ethanone hydrochloride

Similarity: 0.56

Chemical Structure| 5874-61-3

[ 5874-61-3 ]

4-Benzyl-2-phenyloxazol-5(4H)-one

Similarity: 0.56

Chemical Structure| 136450-06-1

[ 136450-06-1 ]

N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide

Similarity: 0.55

Ethers

Chemical Structure| 51463-14-0

[ 51463-14-0 ]

6-Methoxyisoquinolin-3(2H)-one

Similarity: 0.68

Chemical Structure| 4721-98-6

[ 4721-98-6 ]

6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline

Similarity: 0.57

Chemical Structure| 129722-25-4

[ 129722-25-4 ]

7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one

Similarity: 0.56

Chemical Structure| 34589-97-4

[ 34589-97-4 ]

2-Amino-1-(2-methoxyphenyl)ethanone hydrochloride

Similarity: 0.56

Chemical Structure| 3271-05-4

[ 3271-05-4 ]

6-Methoxy-2-methyl-1H-benzo[de]isoquinoline-1,3(2H)-dione

Similarity: 0.56

Amides

Chemical Structure| 51463-14-0

[ 51463-14-0 ]

6-Methoxyisoquinolin-3(2H)-one

Similarity: 0.68

Chemical Structure| 26138-64-7

[ 26138-64-7 ]

3-Acetyl-4-hydroxyquinolin-2(1H)-one

Similarity: 0.68

Chemical Structure| 262847-54-1

[ 262847-54-1 ]

2,3-Dihydrobenzofuran-5-carboxamide

Similarity: 0.57

Chemical Structure| 129722-25-4

[ 129722-25-4 ]

7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one

Similarity: 0.56

Chemical Structure| 3271-05-4

[ 3271-05-4 ]

6-Methoxy-2-methyl-1H-benzo[de]isoquinoline-1,3(2H)-dione

Similarity: 0.56

Ketones

Chemical Structure| 26138-64-7

[ 26138-64-7 ]

3-Acetyl-4-hydroxyquinolin-2(1H)-one

Similarity: 0.68

Chemical Structure| 1345515-22-1

[ 1345515-22-1 ]

1-(3-Hydroxy-2-methylquinolin-4-yl)ethanone

Similarity: 0.60

Chemical Structure| 4504-87-4

[ 4504-87-4 ]

Dibenzo[b,e]oxepin-11(6H)-one

Similarity: 0.58

Chemical Structure| 1477-19-6

[ 1477-19-6 ]

(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

Similarity: 0.57

Chemical Structure| 196597-78-1

[ 196597-78-1 ]

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one

Similarity: 0.56

Related Parent Nucleus of
[ 93609-84-8 ]

Quinolines

Chemical Structure| 26138-64-7

[ 26138-64-7 ]

3-Acetyl-4-hydroxyquinolin-2(1H)-one

Similarity: 0.68

Chemical Structure| 1345515-22-1

[ 1345515-22-1 ]

1-(3-Hydroxy-2-methylquinolin-4-yl)ethanone

Similarity: 0.60

Chemical Structure| 50741-53-2

[ 50741-53-2 ]

6-Hydroxy-2-methylquinoline-4-carboxylic acid

Similarity: 0.55

Chemical Structure| 1688656-69-0

[ 1688656-69-0 ]

Ethyl 4-ethoxyquinoline-7-carboxylate

Similarity: 0.53

Chemical Structure| 5965-59-3

[ 5965-59-3 ]

Methyl 4-hydroxyquinoline-2-carboxylate

Similarity: 0.53